• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

头孢他啶和奈替米星在脓毒症患者中的药代动力学

Pharmacokinetics of ceftazidime and netilmicin in patients with sepsis.

作者信息

Ganzinger U, Kleinberger G, Lenz K, Schatz F, Laggner A, Grimm G

出版信息

Int J Clin Pharmacol Ther Toxicol. 1987 Jul;25(7):354-62.

PMID:3305380
Abstract

The pharmacokinetics of ceftazidime and netilmicin were evaluated under septicemic conditions. In a longitudinal study, both drugs were administered simultaneously (ceftazidime 2.0 g 20 min constant i.v. infusion and netilmicin 150 mg i.v. bolus injection) every 12 hours to patients who had a positive blood culture and hyperdynamic circulatory functions. Twenty-four hours after the first period of this pharmacokinetic study, identical parameters were evaluated under dipyrone induced normothermic conditions. The mean residence time and the volume of distribution was significantly altered during septicemia compared to normal conditions. With respect to the relative distribution properties ceftazidime tended to be distributed to a greater extent to the tissue compartment, whereas netilmicin showed an opposite behaviour. Beside significant correlations of absolute values, i.e. blood volume vs. volume of distribution, and relative values, i.e. total peripheral resistance vs. extraction rate, all other attempts failed to show any meaningful correlation. Owing to the heterogenous alterations of metabolic and hemodynamic functions and pharmacokinetic parameters, respectively, the data gained from this study do not allow any statistically validated conclusion regarding the pathophysiological mechanisms involved, although these findings are in accordance with animal experiments.

摘要

在败血症条件下评估了头孢他啶和奈替米星的药代动力学。在一项纵向研究中,对血培养呈阳性且循环功能亢进的患者每12小时同时给予两种药物(头孢他啶2.0 g静脉恒速输注20分钟,奈替米星150 mg静脉推注)。在该药代动力学研究的第一个阶段24小时后,在安乃近诱导的正常体温条件下评估相同的参数。与正常情况相比,败血症期间平均驻留时间和分布容积有显著改变。就相对分布特性而言,头孢他啶倾向于在更大程度上分布到组织隔室,而奈替米星则表现出相反的行为。除了绝对值(即血容量与分布容积)和相对值(即总外周阻力与提取率)之间存在显著相关性外,其他所有尝试均未显示出任何有意义的相关性。由于代谢和血流动力学功能以及药代动力学参数分别存在异质性改变,尽管这些发现与动物实验一致,但本研究获得的数据不允许就所涉及的病理生理机制得出任何经统计学验证的结论。

相似文献

1
Pharmacokinetics of ceftazidime and netilmicin in patients with sepsis.头孢他啶和奈替米星在脓毒症患者中的药代动力学
Int J Clin Pharmacol Ther Toxicol. 1987 Jul;25(7):354-62.
2
A prospective randomized trial of ceftazidime versus netilmicin plus mezlocillin in the empirical therapy of presumed sepsis in cirrhotic patients.头孢他啶与奈替米星加美洛西林用于肝硬化患者疑似脓毒症经验性治疗的前瞻性随机试验。
Hepatology. 1997 Apr;25(4):833-6. doi: 10.1002/hep.510250408.
3
Serum bactericidal activity of ceftazidime increased by netilmicin.奈替米星增强了头孢他啶的血清杀菌活性。
Drug Intell Clin Pharm. 1985 Dec;19(12):932-6. doi: 10.1177/106002808501901215.
4
Ceftazidime in the treatment of Pseudomonas infections in intensive-care patients.头孢他啶治疗重症监护患者的假单胞菌感染
Int J Clin Pharmacol Ther Toxicol. 1986 Sep;24(9):457-9.
5
NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).香豆素(CAS编号91-64-5)在F344/N大鼠和B6C3F1小鼠中的NTP毒理学和致癌性研究(灌胃研究)
Natl Toxicol Program Tech Rep Ser. 1993 Sep;422:1-340.
6
Netilmicin pharmacokinetics in uremic patients undergoing hemodialysis.奈替米星在接受血液透析的尿毒症患者中的药代动力学。
Chemioterapia. 1986 Oct;5(5):327-9.
7
Aminoglycoside redistribution phenomenon after hemodialysis: netilmicin and tobramycin.血液透析后氨基糖苷类药物的再分布现象:奈替米星和妥布霉素
Int J Clin Pharmacol Ther Toxicol. 1987 Jan;25(1):50-5.
8
Comparison of clinical cure rates in adults with ventilator-associated pneumonia treated with intravenous ceftazidime administered by continuous or intermittent infusion: a retrospective, nonrandomized, open-label, historical chart review.持续输注与间歇输注静脉用头孢他啶治疗成人呼吸机相关性肺炎的临床治愈率比较:一项回顾性、非随机、开放标签、历史病历回顾研究。
Clin Ther. 2007 Nov;29(11):2433-9. doi: 10.1016/j.clinthera.2007.11.003.
9
Pharmacokinetics of ceftazidime in elderly patients and young volunteers.头孢他啶在老年患者和年轻志愿者中的药代动力学。
Scand J Infect Dis. 1984;16(3):325-6. doi: 10.3109/00365548409070410.
10
Radiation-induced changes of brain tissue after radiosurgery in patients with arteriovenous malformations: correlation with dose distribution parameters.动静脉畸形患者放射外科治疗后脑组织的辐射诱导变化:与剂量分布参数的相关性
Int J Radiat Oncol Biol Phys. 2004 Jul 1;59(3):796-808. doi: 10.1016/j.ijrobp.2003.11.033.

引用本文的文献

1
Pharmacokinetic-pharmacodynamic evaluation of ceftazidime continuous infusion vs intermittent bolus injection in septicaemic melioidosis.头孢他啶持续输注与间歇静脉推注治疗败血症型类鼻疽的药代动力学-药效学评价
Br J Clin Pharmacol. 2000 Aug;50(2):184-91. doi: 10.1111/j.1365-2125.2000.00179.x.
2
Pharmacokinetic-pharmacodynamic evaluation of ceftazidime continuous infusion vs intermittent bolus injection in septicaemic melioidosis.头孢他啶持续输注与间歇静脉推注治疗败血症型类鼻疽的药代动力学-药效学评价
Br J Clin Pharmacol. 2000 May;49(5):445-52. doi: 10.1046/j.1365-2125.2000.00179.x.
3
Ceftazidime. An update of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy.
头孢他啶。其抗菌活性、药代动力学特性及治疗效果的最新进展。
Drugs. 1995 Apr;49(4):577-617. doi: 10.2165/00003495-199549040-00008.
4
Pharmacokinetics of cefonicid in patients with skin and skin structure infections.头孢尼西在皮肤及皮肤结构感染患者中的药代动力学
Antimicrob Agents Chemother. 1988 Apr;32(4):485-7. doi: 10.1128/AAC.32.4.485.
5
Disposition of ceftazidime in surgical patients with intra-abdominal infection.头孢他啶在腹腔内感染外科患者中的处置情况。
Antimicrob Agents Chemother. 1988 Dec;32(12):1845-7. doi: 10.1128/AAC.32.12.1845.
6
Pharmacokinetics of cefepime in patients with respiratory tract infections.头孢吡肟在呼吸道感染患者中的药代动力学。
Antimicrob Agents Chemother. 1990 Oct;34(10):1885-8. doi: 10.1128/AAC.34.10.1885.
7
Clinical pharmacokinetics 1990.临床药代动力学,1990年
Clin Pharmacokinet. 1990 Jan;18(1):1-19. doi: 10.2165/00003088-199018010-00001.
8
Steady-state pharmacokinetics of fleroxacin in patients with skin and skin structure infections.氟罗沙星在皮肤及皮肤结构感染患者中的稳态药代动力学。
Antimicrob Agents Chemother. 1990 May;34(5):922-3. doi: 10.1128/AAC.34.5.922.
9
Steady-state pharmacokinetics and sputum penetration of lomefloxacin in patients with chronic obstructive pulmonary disease and acute respiratory tract infections.洛美沙星在慢性阻塞性肺疾病合并急性呼吸道感染患者中的稳态药代动力学及痰液穿透性
Antimicrob Agents Chemother. 1992 Nov;36(11):2458-61. doi: 10.1128/AAC.36.11.2458.